Cited by 327Sexual function and dysfunction studiesHormonal and reproductive studiesCardiovascular Health and Disease Prevention

The Second Princeton Consensus on Sexual Dysfunction and Cardiac Risk: New Guidelines for Sexual Medicine

Jackson, Graham, Rosen, Raymond C., Kloner, Robert A., Kostis, John B.·2006·The Journal of Sexual Medicine

Abstract

Introduction Erectile dysfunction (ED) is a highly prevalent disorder associated with a significant burden of illness. The prevalence and incidence of ED are strongly age-related, affecting more than half of men >60 years. The first Princeton Consensus Conference (Princeton I) in 1999 developed guidelines for safe management of cardiac patients regarding sexual activity and the treatment of ED. Aim The second conference (Princeton II) was convened to update the recommendations based on the expanding knowledge base and new treatments available. This article reviews and expands on the Princeton II guidelines to address sexual dysfunction and cardiac risk. Methods A consensus panel of experts reviewed recent multinational studies in safety and drug interaction data for three phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil), with emphasis on the safety of these agents in men with ED and concomitant cardiovascular disease. Results Erectile dysfunction is an early symptom or harbinger of cardiovascular disease, due to the common risk factors and pathophysiology mediated through endothelial dysfunction. Major comorbidities include diabetes, hypertension, hyperlipidemia and heart disease. Any asymptomatic man who presents with ED that does not have an obvious cause (e.g., trauma) should be screened for vascular disease and have blood glucose, lipids, and blood pressure measurements. Ideally, all patients at risk but asymptomatic for coronary disease shou…

Integrity signals

Registry

Crossref · 10.1111/j.1743-6109.2005.00196.x

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 52 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Jackson, G., Rosen, R. C., Kloner, R. A., & Kostis, J. B.
Affiliations
  • St Thomas' Hospital (GB)
  • University of Medicine and Dentistry of New Jersey (US)
  • University of Southern California (US)
Corresponding author
Jackson, Graham
Venue
The Journal of Sexual Medicine
Published
2006-01-01
Volume
3
Issue
1
Pages
28-36
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W2033049068
Cited by
327
References
52
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 9 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 15 · 2015: 10 · 2014: 23 · 2013: 17 · 2012: 22
FWCI
29.34
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Sexual Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords
erectile dysfunction, cardiovascular risk, phosphodiesterase-5 inhibitors, sildenafil, tadalafil, vardenafil, drug safety, drug interactions, endothelial dysfunction, cardiovascular screening, exercise electrocardiography, lifestyle modification, weight loss, physical activity
MeSH terms
Adult, Aging, Cardiovascular Agents, Coronary Disease, Drug Interactions, Hemodynamics, Humans, Erectile Dysfunction, Life Style, Male, Middle Aged, Patient Education as Topic, Phosphodiesterase Inhibitors, Risk Factors, Vasodilator Agents, Comorbidity, Practice Guidelines as Topic, Impotence, Vasculogenic, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review